FDA clears Vital Images universal viewer

| | Health Imaging | Enterprise Imaging

Vital Images, part of the Toshiba Medical Systems Group, has received FDA 510(k) clearance for 3D viewing through its universal viewer, VitreaView. The company simultaneously released its tablet viewing capabilities for VitreaView.

Introduced in June 2011, VitreaView is used as a communication tool for DICOM and non-DICOM medical images through a standardized viewer, giving clinicians access to these images through a variety of systems, including an EHR or health information exchange.

The technology allows access to multiple databases, providing a universal imaging layer at the enterprise level. VitreaView is designed to eliminate the need to integrate image viewing portals by providing one standardized imaging layer for referring clinicians, according to Minneapolis-based Vital. 

Related Content

Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
Residents' structured reports get boost from software assistance
Do large language models help or hinder workflows related to radiology reports?
Telehealth visits not to blame for uptick in imaging orders, study shows
Up to half of medical organizations either already using or preparing to implement AI

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.